Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers shares jump on news of Mead Johnson split
Marketwatch
Monday, November 16, 2009 - 6:43pm
tags:
Bristol-Myers Squibb, Mead Johnson
NeurogesX receives Food and Drug Administration approval for Qutenza pain patch
Yahoo/AP
Monday, November 16, 2009 - 5:36pm
tags:
FDA, pain patches, Qutenza, NeurogesX
Contamination Issues Haunt Genzyme
Yahoo/Zacks.com
Monday, November 16, 2009 - 11:08am
tags:
Genzyme
A Closer Look at Cardium's Wound-Healing Drug
TheStreet.com
Monday, November 16, 2009 - 11:07am
tags:
Cardium
Par Pharma gets FDA nod for generic version of Ultram
Reuters
Monday, November 16, 2009 - 10:41am
tags:
generics, Par Pharmaceutical, Ultram, painkillers
Bristol-Myers, Merck lead drug stocks higher
Marketwatch
Monday, November 16, 2009 - 10:35am
tags:
Merck, drug stocks, Bristol-Myers Squibb
Fate Therapeutics Seals $30 M Series B, Gets Corporate Venture On Board
InVivo
Monday, November 16, 2009 - 10:33am
tags:
Fate Therapeutics, Genzyme, Astellas
Human Genome's anthrax drug denied approval
Reuters
Monday, November 16, 2009 - 10:32am
tags:
anthrax, FDA, Human Genome Sciences
Cell Therapeutics Lavishes Free Stock on Execs
TheStreet.com
Monday, November 16, 2009 - 10:29am
tags:
Cell Therapeutics
An Odd Mix: Health Care Reform & Higher Rx Prices
Pharmalot
Monday, November 16, 2009 - 10:01am
tags:
healthcare reform, drug prices
Poniard Pharma says picoplatin did not improve survival in late stage study; shares tumble
Yahoo/AP
Monday, November 16, 2009 - 9:59am
tags:
Poniard, drug studies, cancer, picoplatin
[video] Cholesterol Drug Battle: Merck vs. Abbott Labs
CNBC
Monday, November 16, 2009 - 9:25am
tags:
Vytorin, Niaspan, Merck, cholesterol, Abbott Laboratories, Zetia
Lilly's new development star signals strategic shift
Fierce Biotech
Monday, November 16, 2009 - 9:23am
tags:
Eli Lilly, R&D
Playing the Options Game in RIM; Cel Sci Not Yet Trading to Its Potential
Seeking Alpha
Monday, November 16, 2009 - 9:22am
tags:
options, Cel-Sci
GlaxoSmithKline could pay Nabi more than $500 million in deal to develop anti-smoking vaccines
Yahoo/AP
Monday, November 16, 2009 - 9:11am
tags:
GSK, Nabi, vaccines, partnerships, smoking cessation
Bayer, Novartis, Sanofi-Aventis Rated New ‘Buy’ at Deutsche Bank
Bloomberg
Monday, November 16, 2009 - 9:10am
tags:
upgrades, Bayer, Novartis, Sanofi
Sanofi-Aventis says flu vaccine approved in France
Marketwatch
Monday, November 16, 2009 - 9:07am
tags:
France, Sanofi, vaccines, swine flu, H1N1
Another Vytorin Mess For Merck
Forbes
Monday, November 16, 2009 - 9:06am
tags:
Merck, Zetia, Vytorin
Bristol-Myers to split off Mead Johnson
Marketwatch
Monday, November 16, 2009 - 8:49am
tags:
Bristol-Myers Squibb, Mead Johnson, reorganization
What Genentech and Roche Got From Congress for $15M
BNET Pharma
Sunday, November 15, 2009 - 6:17pm
tags:
Roche, congress, Genentech, healthcare reform

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.